The emerging landscape of breast cancer susceptibility

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069

Identification of the breast cancer susceptibility gene BRCA2

Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645

Patterns of somatic mutation in human cancer genomes

Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143

A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase

Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785

Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21

Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544

Genome-wide association study identifies novel breast cancer susceptibility loci

Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319

Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13

Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K. N., Seal, S., Tran, T. D., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,918

Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09454-0 · Cited by 1,577

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

Hunter, D. J., Kraft, P. L., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R. A., Hutchinson, A. A., et al. (2007) · Nature Genetics · doi:10.1038/ng2075 · Cited by 1,487

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891

Common and rare variants in multifactorial susceptibility to common diseases

Bodmer, W., & Bonilla, C. (2008) · Nature Genetics · doi:10.1038/ng.f.136 · Cited by 1,131

Common disorders are quantitative traits

Plomin, R., Haworth, C. M. A., & Davis, O. S. P. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2670 · Cited by 670

RAD51B in Familial Breast Cancer

Pelttari, L. M., Khan, S., Vuorela, M., Kiiski, J. I., Vilske, S., Nevanlinna, V., Ranta, S., Schleutker, J., Winqvist, R., Kallioniemi, A. H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153788 · Cited by 672

Genetics of breast cancer: a topic in evolution

Shiovitz, S., & Korde, L. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv022 · Cited by 577

Mechanisms of resistance to therapies targeting BRCA-mutant cancers

Lord, C. J., & Ashworth, A. (2013) · Nature Medicine · doi:10.1038/nm.3369 · Cited by 467

Susceptibility Pathways in Fanconi's Anemia and Breast Cancer

D’Andrea, A. D. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809889 · Cited by 390

Single-Nucleotide Polymorphisms Inside MicroRNA Target Sites Influence Tumor Susceptibility

Nicoloso, M. S., Sun, H., Spizzo, R., Kim, H., Wickramasinghe, P., Shimizu, M., Wojcik, S. E., Ferdin, J., Kunej, T., Xiao, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3541 · Cited by 381

Progress and challenges in genome-wide association studies in humans

Donnelly, P. (2008) · Nature · doi:10.1038/nature07631 · Cited by 366

Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence

Zhang, B., Beeghly-Fadiel, A. C., Long, J., & Zheng, W. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70076-6 · Cited by 276

A Novel Adaptive Method for the Analysis of Next-Generation Sequencing Data to Detect Complex Trait Associations with Rare Variants Due to Gene Main Effects and Interactions

Liu, D. J., & Leal, S. M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001156 · Cited by 245

Rare variants in the ATMgene and risk of breast cancer

Goldgar, D. E., Healey, S. C., Dowty, J. G., Silva, L. M. D., Chen, X., Spurdle, A. B., Terry, M. B., Daly, M., Buys, S. M., Southey, M. C., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2919 · Cited by 241

The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection

Coleman, K. A., & Greenberg, R. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213728 · Cited by 234

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Southey, M. C., Goldgar, D. E., Winqvist, R., Pylkäs, K., Couch, F. J., Tischkowitz, M. D., Foulkes, W. D., Dennis, J., Michailidou, K., van Rensburg, E. J., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103839 · Cited by 213

Breast cancer susceptibility: current knowledge and implications for genetic counselling

Ripperger, T., Gadzicki, D., Meindl, A., & Schlegelberger, B. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.212 · Cited by 221

Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes

Johnston, J. J., Rubinstein, W. S., Facio, F. M., Ng, D., Singh, L. N., Teer, J. K., Mullikin, J. C., & Biesecker, L. G. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.021 · Cited by 207

Familial Breast Cancer

Lalloo, F. I., & Evans, D. G. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01859.x · Cited by 220

PALB2/FANCN: Recombining Cancer and Fanconi Anemia

Tischkowitz, M. D., & Xia, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1012 · Cited by 199

Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer

Tavtigian, S. V., Oefner, P. J., Babikyan, D., Hartmann, A., Healey, S. C., Calvez‐Kelm, F. L., Lesueur, F., Byrnes, G. B., Chuang, S., Forey, N., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.08.018 · Cited by 195

Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer

Corpet, A., de Koning, L., Toedling, J., Savignoni, A., Berger, F., Boumendil, C., O’Sullivan, R. J., Karlseder, J., Barillot, E., Asselain, B. J. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.335 · Cited by 198

Epidemiology of Breast Cancer

Ban, K. A., & Godellas, C. V. (2014) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2014.03.011 · Cited by 202

Evolution of the cancer genome

Podlaha, O., Riester, M., De, S., & Michor, F. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.01.003 · Cited by 188

How can we realize the promise of personalized antidepressant medicines?

Holsboer, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2453 · Cited by 177

Prediction of individual genetic risk of complex disease

Wray, N. R., Goddard, M. E., & Visscher, P. M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.006 · Cited by 167

Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer

Galvan, A., Ioannidis, J. P. A., & Dragani, T. A. (2010) · Trends in Genetics · doi:10.1016/j.tig.2009.12.008 · Cited by 156

High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Manié, É., Vincent‐Salomon, A., Lehmann‐Che, J., Pierron, G., Turpin, E., Warcoin, M., Gruel, N., Lebigot, I., Sastre‐Garau, X., Lidereau, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1560 · Cited by 152

Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study

Evans, D. G., Astley, S., Stavrinos, P., Harkness, E. F., Donnelly, L. S., Dawe, S., Jacob, I., Harvie, M., Cuzick, J. M., Brentnall, A. R., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04110 · Cited by 153

Detecting rare variants for complex traits using family and unrelated data

Zhu, X., Feng, T., Li, Y., Lu, Q. L., & Elston, R. C. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20449 · Cited by 135

Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer

Wendt, C., & Margolin, S. (2019) · Acta Oncologica · doi:10.1080/0284186x.2018.1529428 · Cited by 144

Biosensor-based diagnostic approaches for various cellular biomarkers of breast cancer: A comprehensive review

Ranjan, P., Parihar, A., Jain, S., Kumar, N., Dhand, C., Murali, S., Mishra, D., Sanghi, S. K., Chaurasia, J. P., Srivastava, A. K., et al. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113996 · Cited by 136

Learning From Molecular Genetics

McCarthy, M. I., & Hattersley, A. T. (2008) · Diabetes · doi:10.2337/db08-0343 · Cited by 132

Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence

Ma, X., Zhang, B., & Zheng, W. (2013) · Gut · doi:10.1136/gutjnl-2012-304121 · Cited by 125

Methods for Genomic Partitioning

Turner, E. H., Ng, S. B. H., Nickerson, D. A., & Shendure, J. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150112 · Cited by 131

Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study

Borg, Å., Haile, R. W., Malone, K. E., Capanu, M., Diep, A., Törngren, T., Teraoka, S. N., Begg, C. B., Thomas, D. C., CONCANNON, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21202 · Cited by 128

Assessing Risk of Breast Cancer: A Review of Risk Prediction Models

Kim, G., & Bahl, M. (2021) · Journal of Breast Imaging · doi:10.1093/jbi/wbab001 · Cited by 122

Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor

Shahid, T., Soroka, J., Kong, E. H., Malivert, L., McIlwraith, M. J., Pape, T., West, S. C., & Zhang, X. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2899 · Cited by 124

A PALB2 mutation associated with high risk of breast cancer

Southey, M. C., Teo, Z. L., Dowty, J. G., Odefrey, F., Park, D. J., Tischkowitz, M. D., Sabbaghian, N., Apicella, C., Byrnes, G. B., Winship, I., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2796 · Cited by 118

Translational advances regarding hereditary breast cancer syndromes

Gage, M. M., Wattendorf, D. J., & Henry, L. R. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.21856 · Cited by 118

A High Proportion of DNA Variants of BRCA1 and BRCA2 Is Associated with Aberrant Splicing in Breast/Ovarian Cancer Patients

Sanz, D. J., Acedo, A., Infante, M., Durán, M., Pérez‐Cabornero, L., Esteban‐Cardeñosa, E., Lastra, E., Pagani, F., Miner, C., & Velasco, E. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2564 · Cited by 109

Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1

Cantor, S. B., & Guillemette, S. (2011) · Future Oncology · doi:10.2217/fon.10.191 · Cited by 106

Discovering moderate-risk breast cancer susceptibility genes

Hollestelle, A., Wasielewski, M., Martens, J. W. M., & Schutte, M. E. M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.02.009 · Cited by 109

The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer

Möller, S., Mucci, L. A., Harris, J. R., Scheike, T., Holst, K. K., Halekoh, U., Adami, H., Czene, K., Christensen, K., Holm, N. V., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0913 · Cited by 105

Germline variation in BRCA1/2 is highly ethnic‐specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients

Bhaskaran, S. P., Chandratre, K. R., Gupta, H., Zhang, L., Wang, X., Cui, J., Kim, Y. C., Sinha, S., Jiang, L., Lu, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32176 · Cited by 106

Pathology of hereditary breast cancer

Silva, L. M. D., & Lakhani, S. R. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.37 · Cited by 101

Male breast cancer: genetics, epigenetics, and ethical aspects

Rizzolo, P., Silvestri, V., Tommasi, S., Pinto, R., Danza, K., Falchetti, M., Gulino, M., Frati, P., & Ottini, L. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt316 · Cited by 102

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

Wong‐Brown, M. W., Nordfors, C., Mossman, D., Pecenpetelovska, G., Avery‐Kiejda, K. A., Talseth‐Palmer, B. A., Bowden, N. A., & Scott, R. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1443-0 · Cited by 104

Biomarker Studies in Early Detection and Prognosis of Breast Cancer

Li, G., Hu, J., & Hu, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_2 · Cited by 98

Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients

Pastrello, C., Polesel, J., Puppa, L. D., Viel, A., & Maestro, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq184 · Cited by 97

Family History, Mammographic Density, and Risk of Breast Cancer

Martin, L. J., Melnichouk, O., Guo, H., Chiarelli, A. M., Hislop, T. G., Yaffe, M. J., Minkin, S., Hopper, J. L., & Boyd, N. F. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0881 · Cited by 96

Homologous recombination proficiency in ovarian and breast cancer patients

Creeden, J. F., Nanavaty, N. S., Einloth, K. R., Gillman, C. E., Stanbery, L., Hamouda, D., Dworkin, L. D., & Nemunaitis, J. J. (2021) · BMC Cancer · doi:10.1186/s12885-021-08863-9 · Cited by 96

Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family Study

Mouchawar, J., Korch, C. T., Byers, T., Pitts, T. M., Li, E., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Southey, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-0851 · Cited by 92

Comprehensive review on the electrochemical biosensors of different breast cancer biomarkers

Mostafa, I. M., Tian, Y., Anjum, S., Hanif, S., Hosseini, M., Lou, B., & Xu, G. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.131944 · Cited by 91

Machine learning approaches for the discovery of gene-gene interactions in disease data

Upstill‐Goddard, R., Eccles, D., Fliege, J., & Collins, A. R. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs024 · Cited by 94

The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance

Skol, A. D., Sasaki, M. M., & Onel, K. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0759-4 · Cited by 97

Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study

Calvez‐Kelm, F. L., Lesueur, F., Damiola, F., Vallée, M., Voegele, C., Babikyan, D., Durand, G., Forey, N., McKay‐Chopin, S., Robinot, N. R., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2810 · Cited by 89

In search of low-frequency and rare variants affecting complex traits

Panoutsopoulou, K., Tachmazidou, I., & Zeggini, E. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt376 · Cited by 90

Research needs in breast cancer

Cardoso, F., Harbeck, N., Barrios, C. H., Bergh, J. C. S., Cortés, J., Saghir, M. Z., Francis, P. A., Hudis, C. A., Ohno, S., Partridge, A. H., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw571 · Cited by 89

Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer

Zhu, M., Yan, C., Ren, C., Huang, X., Zhu, X., Gu, H., Wang, M., Wang, S., Gao, Y., Ji, Y. I., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.017 · Cited by 86

Hereditary breast cancer: syndromes, tumour pathology and molecular testing

Sokolova, A., Johnstone, K. J., Reed, A. E. M., Simpson, P. T., & Lakhani, S. R. (2022) · Histopathology · doi:10.1111/his.14808 · Cited by 95

Risk Prediction of Complex Diseases from Family History and Known Susceptibility Loci, with Applications for Cancer Screening

So, H., Kwan, J. S. H., Cherny, S. S., & Sham, P. C. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.001 · Cited by 81

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report

Bernstein, J. L., Thomas, D. C., Shore, R. E., Robson, M. E., Boice, J. D., Stovall, M. A., Andersson, M., Bernstein, L., Malone, K. E., Reiner, A. S., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.028 · Cited by 81

Exploring genetic modifiers of Gaucher disease: The next horizon

Davidson, B. A., Hassan, S., Garcia, E. J., Tayebi, N., & Sidransky, E. (2018) · Human Mutation · doi:10.1002/humu.23611 · Cited by 79

Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

Fang, C.-B., Wu, H.-T., Zhang, M., Liu, J., & Zhang, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00160 · Cited by 82

Epidemiology of breast cancer in young women

Pollán, M. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1098-2 · Cited by 73

Genome-Wide Testing of Putative Functional Exonic Variants in Relationship with Breast and Prostate Cancer Risk in a Multiethnic Population

Haiman, C. A., Han, Y., Feng, Y., Xia, L. Y., Hsu, C., Sheng, X., Pooler, L., Patel, Y. M., Kolonel, L. N., Carter, E., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003419 · Cited by 71

Detecting Association of Rare and Common Variants by Testing an Optimally Weighted Combination of Variants

Sha, Q., Wang, X., Wang, X., & Zhang, S. (2012) · Genetic Epidemiology · doi:10.1002/gepi.21649 · Cited by 72

Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population

Morales, S., Gulppi, F., González‐Hormazábal, P., Fernández‐Ramires, R., Bravo, T., Reyes, J. M., Gómez, F., Waugh, E., & Lilian Jara, S. (2016) · BMC Genetics · doi:10.1186/s12863-016-0415-0 · Cited by 69

A Loss-of-Function Polymorphism in the Propeptide Domain of the LOX Gene and Breast Cancer

Min, C., Yu, Z., Kirsch, K. H., Zhao, Y., Vora, S. R., Trackman, P. C., Spicer, D. B., Rosenberg, L. A., Palmer, J. R., & Sonenshein, G. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4818 · Cited by 70

Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)

Terry, M. B., Phillips, K., Daly, M. B., John, E. M., Andrulis, I. L., Buys, S. S., Goldgar, D. E., Knight, J. A., Whittemore, A. S., Chung, W. K., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv118 · Cited by 66

Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing

Horvath, A., Pakala, S. B., Mudvari, P., Reddy, S. D. N., Ohshiro, K., Casimiro, S., Pires, R., Fuqua, S. A. W., Toi, M., Costa, L., et al. (2013) · Scientific Reports · doi:10.1038/srep02256 · Cited by 65

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care

Graffeo, R., Livraghi, L., Pagani, O., Goldhirsch, A., Partridge, A. H., & Garber, J. E. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4003-9 · Cited by 69

Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18

Fraile‐Bethencourt, E., Díez‐Gómez, B., Velásquez‐Zapata, V., Acedo, A., Sanz, D. J., & Velasco, E. A. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006691 · Cited by 67

Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function

Nikkilä, J., Coleman, K. A., Morrissey, D., Pylkäs, K., Erkko, H., Messick, T. E., Karppinen, S.-M., Amelina, A., Winqvist, R., & Greenberg, R. A. (2009) · Oncogene · doi:10.1038/onc.2009.33 · Cited by 63

BRCA Gene Structure and Function in Tumor Suppression

Murphy, C. G., & Moynahan, M. E. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181cf0204 · Cited by 63

Hereditary breast cancer: From molecular pathology to tailored therapies

Tan, D. S. P., Marchiò, C., & Reis-Filho, J. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.057950 · Cited by 60

Replication of Breast Cancer GWAS Susceptibility Loci in the Women's Health Initiative African American SHARe Study

Hutter, C. M., Young, A., Ochs‐Balcom, H. M., Carty, C. L., Wang, T., Chen, C. T. L., Rohan, T. E., Kooperberg, C. L., & Peters, U. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0524 · Cited by 60

Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?

Wilting, J., & Hagedorn, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798347252 · Cited by 59

Breast Cancer–Associated Abraxas Mutation Disrupts Nuclear Localization and DNA Damage Response Functions

Solyom, S., Aressy, B., Pylkäs, K., Patterson-Fortin, J., Hartikainen, J. M., Kallioniemi, A., Kauppila, S., Nikkilä, J., Kosma, V.-M., Mannermaa, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003223 · Cited by 59

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations

Colombo, M., Vecchi, G. D., Caleca, L., Foglia, C., Ripamonti, C. B., Ficarazzi, F., Barile, M., Varesco, L., Peissel, B., Manoukian, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057173 · Cited by 58

Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients

Kim, Y. C., Zhao, L., Zhang, H., Huang, Y., Cui, J., Xiao, F., Downs, B. M., & Wang, S. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7144 · Cited by 58

The ‘Common Disease-Common Variant’ Hypothesis and Familial Risks

Hemminki, K., Försti, A., & Bermejo, J. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002504 · Cited by 57

Germline Genetic Variants Disturbing the Let-7/LIN28 Double-Negative Feedback Loop Alter Breast Cancer Susceptibility

Chen, A.-X., Yu, K., Fan, L., Li, J., Yang, C., Huang, A., & Shao, Z. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002259 · Cited by 56

Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes

Acedo, A., Sanz, D. J., Durán, M., Infante, M., Pérez‐Cabornero, L., Miner, C., & Velasco, E. A. (2012) · Breast Cancer Research · doi:10.1186/bcr3202 · Cited by 58

The genetics of breast cancer: risk factors for disease

Collins, A. R. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s13139 · Cited by 64

Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

Mančíková, V., Cruz, R., Inglada‐Pérez, L., Fernández–Rozadilla, C., Landa, I., Cameselle‐Teijeiro, J., Celeiro‐Muñoz, C., Pastor, S., Velázquez, A., Marcos, R., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29557 · Cited by 55

Functional Classification of BRCA2 DNA Variants by Splicing Assays in a Large Minigene with 9 Exons

Acedo, A., Hernández-Moro, C., Curiel-García, Á., Díez-Gómez, B., & Velasco, E. (2015) · Human Mutation · doi:10.1002/humu.22725 · Cited by 58

Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls

Fletcher, O., Johnson, N., dos‐Santos‐Silva, I., Kilpivaara, O., Aittomäki, K., BLOMQVIST, C. P., Nevanlinna, H. A., Wasielewski, M., Meijers-Heijboer, H. E. J., Broeks, A., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0416 · Cited by 55

Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations

Lilian Jara, S., Morales, S., de Mayo, T., González‐Hormazábal, P., Carrasco, V., & Godoy, R. (2017) · Biological Research · doi:10.1186/s40659-017-0139-2 · Cited by 57

Differences in BRCA counseling and testing practices based on ordering provider type

Cragun, D. L., Camperlengo, L. P., Robinson, E. K., Caldwell, M., Kim, J., Phelan, C., Monteiro, Á. N. A., Vadaparampil, S. T., Sellers, T. A., & Pal, T. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.75 · Cited by 53

A role for XRCC2 gene polymorphisms in breast cancer risk and survival

Lin, W., Camp, N. J., Cannon‐Albright, L., Allen‐Brady, K., Balasubramanian, S. P., Reed, M., Hopper, J. L., Apicella, C., Giles, G. G., Southey, M. C., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100018 · Cited by 52

Coexposure to Phytoestrogens and Bisphenol A Mimics Estrogenic Effects in an Additive Manner

Katchy, A., Pinto, C. L., Jonsson, P., Nguyen-Vu, T., Pandelova, M. E., Riu, A., Schramm, K., Samarov, D. V., Gustafsson, J.-Α., Bondesson, M., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft271 · Cited by 55

Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Shahi, R. B., Brakeleer, S. D., Caljon, B., Pauwels, I., Bonduelle, M., Joris, S., Fontaine, C., Vanhoeij, M., Dooren, S. V., Teugels, E., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5494-7 · Cited by 55

PALB2 analysis in BRCA2-like families

Adank, M. A., van Mil, S. E., Gille, J. J. P., Waisfisz, Q., & Meijers-Heijboer, H. E. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1001-1 · Cited by 53

High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer

Judes, G., Rifai, K. T., Daures, M., Dubois, L., Bignon, Y., Penault-Llorca, F. M., & Bernard-Gallon, D. J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.001 · Cited by 50

Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression

Templeton, A. J., Gonzalez, L. D., Vera-Badillo, F., Tibau, A., Goldstein, R., Šeruga, B., Srikanthan, A., Pandiella, A., Amir, E., & Ocaña, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154789 · Cited by 53

Somatic and germline genetics at the JAK2 locus

Campbell, P. J. (2009) · Nature Genetics · doi:10.1038/ng0409-385 · Cited by 50

Cancer evolution and individual susceptibility

Pérez‐Losada, J., Castellanos‐Martín, A., & Mao, J. (2011) · Integrative Biology · doi:10.1039/c0ib00094a · Cited by 49

Inherited and acquired alterations in development of breast cancer

Ottini, L., Rizzolo, P., Silvestri, V., & Falchetti, M. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s13226 · Cited by 53

Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing

Yang, X., Wu, J., Lu, J., Liu, G., Di, G., Chen, C., Hou, Y., Sun, M., Yang, W., Xu, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125571 · Cited by 47

Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer

BRCAs, I., Guénard, F., Labrie, Y., Ouellette, G., Beauparlant, C. J., & Durocher, F. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.6 · Cited by 48

Breast cancer genetics: What we know and what we need

Nathanson, K. L., Wooster, R., & Weber, B. L. (2001) · Nature Medicine · doi:10.1038/87876 · Cited by 474

Breast Cancer Susceptibility Genes

Deniz, M., & Wiesmüller, L. (2017) · Springer eBooks · doi:10.1007/978-3-662-46875-3_6619 · Cited by 3

Genetic Predisposition to Breast Cancer: Past, Present, and Future

Turnbull, C., & Rahman, N. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164339 · Cited by 315

Risks and Function of Breast Cancer Susceptibility Alleles

Dalivandan, S. T., Plummer, J., & Gayther, S. A. (2021) · Cancers · doi:10.3390/cancers13163953 · Cited by 26

Abstract PL02-05: New insights into genetic susceptibility to breast cancer

Easton, D. F. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.prev-10-pl02-05